An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …

Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease
in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver …

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers, and it is
characterized by genetic and epigenetic alterations, as well as by inflammatory cell …

Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease that can lead to
liver cirrhosis, liver cancer, and ultimately death. NAFLD is pathologically classified as non …

Nonalcoholic fatty liver disease (NAFLD) is a fast growing, chronic liver disease affecting∼
25% of the global population. Nonalcoholic fatty liver disease severity ranges from the less …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease.
Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD can progress to liver …

Background This retrospective, multicenter study evaluated the effect of pemafibrate
treatment on liver function and fibrosis by liver function tests (LFTs) and various fibrotic …

There is accumulating evidence that the circulatory levels of autotaxin (ATX) and
lysophosphatidic acid (LPA) are increased in patients with severe liver disease. However …

The prevalence of obesity or metabolic syndrome is increasing worldwide (globally
metabodemic). Approximately 25% of the adult general population is suffering from …

Pruritus is a debilitating symptom of various cholestatic disorders, including primary biliary
cholangitis (PBC), primary sclerosing cholangitis (PSC) and inherited progressive familial …